toptal.com
Contact us: +1.888.867.7001
Prashant Kudva, Finance Expert in New York, NY, United States
Prashant Kudva

Finance Expert in New York, NY, United States

Member since April 27, 2017
With 10+ years of experience as an investment banker, from analyst through director level, Prashant has advised companies on over $50 billion of M&A and capital raises. His sector expertise includes healthcare, metals & mining, technology, and clean tech. As a freelancer, he enjoys helping companies with financial planning, valuation, capital raising, investor presentations, M&A advisory, and other financial analyses.
Prashant is now available for hire
Hire Prashant

Career Highlights

Education

Select Certifications

Case studies

Load more...

Industry Expertise

  • Finance
  • Venture Capital & Private Equity
  • Healthcare Services
  • Pharmaceuticals
  • Financial Modeling
  • Early-stage Startups
  • Renewable Energy
  • Women's Health

Other Expertise

Employment

  • Business Development | M&A

    2020 - PRESENT
    Editas
    • Worked on strategy and in/out-licensing products for Editas, a leading gene-editing company.
    • Maintained the database of strategic options and priorities in the gene therapy, cell therapy, and gene editing spaces.
    • Worked on all aspects of mergers and acquisitions and in-licensing and out-licensing products that matched the company's goals.
    Focus areas: Mergers & Acquisitions (M&A), Licensing, Intellectual Property Licensing, Fundraising, Life Science, Fundraising Consultant

  • Business Development and M&A

    2019 - PRESENT
    AMAG Pharmaceuticals
    • Worked on M&A and strategic transactions including alliances, in-licensing assets, and out-licensing assets, acquisitions and divestitures.
    • Built financial and market models in valuing and evaluating potential targets.
    • Focused on multiple biotech therapeutic areas including women's health and hematology segments.
    • Led cross-functional teams in M&A transactions ensuring internal and external alignment on deal goals and objectives.
    • Handled transaction negotiation, deal valuation, seeking and evaluating new acquisition opportunities and presenting potential opportunities to the executive team and board.
    Focus areas: Capital Raising, Strategy, Business Development, Valuation, Financial Planning & Analysis (FP&A), Financing, Women's Health, Biotech, Mergers & Acquisitions (M&A), Life Science

  • Vice President and Director (Healthcare Group)

    2011 - 2016
    Stifel
    • Advised companies in the healthcare industry on capital raises (IPOs, private rounds, public follow-on), and M&A transactions.
    • Assisted companies with FP&A, investor decks, valuation analyses, and positioning.
    • Worked with companies to identify assets or companies to acquire or assets to divest.
    • Supported drafting of SEC filings for companies in transactions, including in over six IPOs.
    • Helped companies analyze capital structure and long term business plan goals by analyzing various financial ratios and trends.
    • Worked as group staffer and managed a team of 12 analysts and associates.
    Focus areas: Corporate Finance, Discounted Cash Flow (DCF), Comparable Company Analysis, Investor Presentations, Business Planning, Financial Planning & Analysis (FP&A), Growth Capital Raising, Capital Raising, Financial Modeling, Valuation, Investment Banking, Healthcare, Biotech, Mergers & Acquisitions (M&A), Life Science, Venture Capital, Fundraising Consultant

  • Associate Director

    2009 - 2011
    Standard Chartered
    • Worked on cross-border M&A deals between the U.S. and Asia/Europe.
    • Identified potential targets for U.S. companies in Asia/Europe and vice versa.
    • Conducted valuation, M&A modeling, and other analyses of the complex issues that can arise during a cross-border merger.
    • Assisted clients in meetings and presented the issues that can arise in cross-border mergers.
    • Served as a founding member of the team that set up the necessary infrastructure and base modeling templates.
    • Performed accretion/dilution analyses for companies looking to raise capital to understand optimal capital structure.
    • Developed IRR analysis to view potential LBO returns on transactions.
    Focus areas: Corporate Finance, Sovereign Wealth Funds (SWFs), Private Company Valuation, Comparable Company Analysis, Budgeting, Financial Modeling, Metals & Mining, Valuation Multiples, Valuation, Valuation Modeling, Capital Raising, Financial Planning & Analysis (FP&A), Strategy, Investment Memoranda, Mergers & Acquisitions (M&A), Cross-border M&A, Venture Capital, Fundraising Consultant

  • Senior Analyst

    2007 - 2009
    Lazard Freres
    • Worked on building Lazard's Levelized Cost of Energy (LCOE) analysis.
    • Built various models, including LBO models for companies of various sizes during M&A transactions in the clean tech and TMT spaces.
    • Conducted various financial analyses and helped emerging solar companies with their budgeting and FP&A efforts.
    • Modeled complex solar and wind farms that included complex PTC and ITCs.
    • Aided companies in compiling investor presentations and models for M&A deals.
    • Performed accretion/dilution analyses for companies looking to raise capital to understand optimal capital structure.
    Focus areas: Corporate Finance, TMT, SaaS, Renewable Energy, CleanTech, Investor Presentations, Pitch Decks, Financial Planning & Analysis (FP&A), Strategy, Financial Modeling, Valuation, Mergers & Acquisitions (M&A), Venture Capital, Fundraising Consultant

  • Financial Analyst

    2006 - 2007
    Merrill Lynch
    • Collaborated with Merrill Lynch's TMT corporate finance group to implement capital raises and M&A transactions.
    • Worked on debt structuring complex transactions, including convertibles with bond hedges.
    • Built financial models for company valuation, including LBO analysis and returns on debt/equity.
    • Performed accretion/dilution analyses for companies looking to raise capital to understand optimal capital structure.
    Focus areas: Transaction Comparables, Comparable Company Analysis, Convertible Debt, Transaction Modeling, TMT, Corporate Finance, Mergers & Acquisitions (M&A), Venture Capital, Fundraising Consultant

Education

  • Master's Degree in Biotechnology Enterprise and Entrepreneurship
    2018 - 2020
    Johns Hopkins University - Baltimore, MD
  • Bachelor's Degree in Economics and Political Science
    2001 - 2005
    University of Chicago - Chicago, IL, USA

Certifications

  • FINRA Series 79
    JULY 2009 - PRESENT
    FINRA

To view more profiles

Join Toptal
Share it with others
Hire the top 3% of freelance finance experts TM